The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

7 Mar 2006 07:04

Marchpole Holdings PLC07 March 2006 FOR IMMEDIATE RELEASE 7 March 2006 Marchpole Holdings plc ("Marchpole") MARCHPOLE COMPLETES ACQUISITION OF MODA AMERICA LLC Marchpole Holdings plc, which designs, produces and sells high quality clothingand accessories for six world class brands (Yves Saint Laurent, Boateng,Jean-Charles de Castelbajac ("JCC") and Jean-Charles de Castelbajac / Rossignol,Emanuel Ungaro and Ungaro), today announces the successful completion of itsacquisition of the whole of the issued share capital of Moda America LLC. Moda America is the US licensee for Emanuel Ungaro and the acquisition bringsfive key benefits : - Based on turnover of $20m in the year to 31st December 2005, primarily from major blue chip U.S. retail customers such as Federated, Macy's, Robinson May and Marshall Fields, the Directors anticipate that sales and margins will increase as Moda benefits from Marchpole's design, sourcing and production base. - Marchpole will be launching the diffusion Ungaro homme collection in the UK from Spring/Summer 2007. This collection will be priced at similar levels to the current YSL ranges which the Directors expect to have significant mass market appeal across Marchpole's existing customer base. - The presence of Marchpole in North America and the new distribution relationships accessed through this acquisition will facilitate the launch of the Jean Charles de Castelbajac brands in the US from Autumn/Winter 2006. - Marchpole's relationship with Emanuel Ungaro has been strengthened further, illustrated by the granting of womenswear distribution rights for the US. - The Emanuel Ungaro mainline collection, already established by Marchpole in Europe and Asia, will now be launched into the US, Canada and South America. Total consideration for the acquisition will be $5.5m in cash, to be satisfiedfrom the Company's existing resources, of which $1.0m was paid on completion andthe balance of $4.5m payable on 31st July 2006. Current Trading Outlook With the third quarter now complete and deliveries underway for the new Spring/Summer 2006 collections, the Directors remain confident of the Company meetingmarket expectations of profit before taxation for the current financial year of£5.0m. In addition, the Directors are intending to implement proposals to enable theCompany to buy-in its issued share capital subject to shareholder approval asthey believe that the current share price undervalues the Company and does notadequately reflect the strong future prospects of the business. Chairman Chris Phillips commented: "The acquisition contributes significantly to our strategic objective ofbecoming a truly worldwide manager of luxury brands". For further information contact: MarchpoleGreg Tufnell - Chief Executive 020 7908 7700 BuchananTim Thompson / Nicola Cronk 020 7466 5000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Dec 20206:22 pmRNSAIM Delisting
30th Nov 20207:00 amRNSKey Dates for AIM Delisting
23rd Nov 202012:00 pmRNSMereo appoints Suba Krishnan
16th Nov 202012:00 pmRNSVirtual R&D Day
11th Nov 20207:00 amRNSCancellation of AIM admission
10th Nov 202012:00 pmRNSStifel 2020 Virtual Healthcare Conference
20th Oct 202012:00 pmRNSAppointments of CFO and SVP
19th Oct 202012:00 pmRNSTIGIT IND FDA Clearance
12th Oct 20201:44 pmRNSPDMR Notification
9th Oct 20204:05 pmRNSDirector/PDMR Shareholding
7th Oct 202012:00 pmRNSRegistration Statement Filed with US SEC
29th Sep 202012:00 pmRNSInterim Results for 6 months ended June 30, 2020
28th Sep 20203:21 pmRNSResult of General Meeting
28th Sep 202012:00 pmRNSChanges to Board of Directors
24th Sep 202012:00 pmRNSFDA Rare Pediatric Disease Designation
16th Sep 20201:00 pmRNSNotice of Interim Results
4th Sep 20207:00 amRNSNotice of General Meeting
25th Aug 202012:00 pmRNSInitiation of COVID-19 Respiratory Disease Trial
14th Aug 20207:00 amRNSPDMR Notification
13th Aug 20207:00 amRNSNotification of PDMR Dealing
6th Aug 20207:00 amRNSAppointment of Nominated Adviser & Broker
5th Aug 20207:00 amRNSDirector Dealing
6th Jul 20203:59 pmRNSHolding(s) in Company
6th Jul 20209:34 amRNSBlock Listing Application
30th Jun 20201:39 pmRNSResult of General Meeting
30th Jun 202012:00 pmRNSCSO and SVP appointments
29th Jun 20203:56 pmRNSResult of Annual General Meeting
22nd Jun 20204:33 pmRNSHolding(s) in Company
22nd Jun 202011:06 amRNSSecond Price Monitoring Extn
22nd Jun 202011:00 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSFinal Results for the year ended December 31, 2019
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20205:30 pmRNSHolding(s) in Company
9th Jun 20204:45 pmRNSNotice of General Meeting
8th Jun 20205:56 pmRNSHolding(s) in Company
8th Jun 20205:18 pmRNSHolding(s) in Company
8th Jun 20203:20 pmRNSHolding(s) in Company
5th Jun 20203:55 pmRNSHolding(s) in Company
5th Jun 202012:49 pmRNSHolding(s) in Company
4th Jun 20202:05 pmRNSSecond Price Monitoring Extn
4th Jun 20202:00 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSCompletion of $70 Million Private Placement
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
27th May 202012:00 pmRNSNotice of Annual General Meeting
22nd May 202012:00 pmRNSAnnual General Meeting
21st May 20204:18 pmRNSHolding(s) in Company
27th Mar 202012:00 pmRNSBusiness Update and Directorate Change
6th Mar 20207:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.